Left Atrial Appendage Occlusion Registry (LAAO Registry)

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The Left Atrial Appendage Occlusion Registry (LAAO Registry™) is designed to assess the prevalence, demographics, management, and outcomes of patients undergoing percutaneous and epicardial based left atrial appendage occlusion procedures to reduce the risk of stroke. Patient-level data will be submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). The primary aims of the LAAO Registry are to optimize the outcomes and management of patients through the implementation of evidence-based guideline recommendations in clinical practice, facilitate efforts to improve the quality and safety for patients undergoing percutaneous and epicardial based left atrial appendage procedures, investigate novel quality improvement methods and provide risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary purpose of the LAAO Registry is to serve as a rich source of clinical data to support assessments of short- and long-term safety, comparative and cost effectiveness research, and as a scalable data infrastructure for post market studies.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients, 18 years and older, undergoing percutaneous or epicardial left atrial appendage occlusion procedures

Locations
United States
Washington, D.c.
American College of Cardiology/National Cardiovascular Data Registry (NCDR)
RECRUITING
Washington D.c.
Contact Information
Primary
Mark Fox, CHC, CHPC
mfox@acc.org
202-375-6305
Backup
Christina Koutras, RN, BSN
ckoutras@acc.org
202-375-6387
Time Frame
Start Date: 2015-12
Estimated Completion Date: 2026-01
Participants
Target number of participants: 3000
Treatments
Atrial Fibrillation
Those patients with the condition of atrial fibrillation.
Related Therapeutic Areas
Sponsors
Leads: American College of Cardiology

This content was sourced from clinicaltrials.gov